首页>
外国专利>
DEVELOPMENT OF NOVEL GENE THERAPEUTICS INFLAMMATION-INDUCED BONE LOSS
DEVELOPMENT OF NOVEL GENE THERAPEUTICS INFLAMMATION-INDUCED BONE LOSS
展开▼
机译：新型基因治疗炎症性骨丢失的研究进展
展开▼
页面导航
摘要
著录项
相似文献
摘要
Aspects of the disclosure relate to compositions and methods for reding inflammation and/or inhibiting bone loss (e.g., bone loss induced by inflammation). In some embodiments, the disclosure provides isolated nucleic acids and expression constructs (e.g., rAAVs, etc.) that encode one or more of the following transgenes: inhibitory nucleic acids targeting Schnurri 3 (SHN3), inhibitory nucleic acids targeting Cathepsin K (CTSK), inhibitory nucleic acids targeting sclerostin (SOST), inhibitory nucleic acids targeting receptor activator of NF-κβ (RANK), inhibitory nucleic acids targeting receptor activator of NF-κβ ligand (RANKL), soluble TNF-α Receptor 2 (sTNFR2), and soluble IL-1 Receptor Antagonist (sIL1Rα). In some embodiments, compositions described by the disclosure are useful for treating diseases associated with inflammation, for example rheumatoid arthritis (RA).
展开▼
